Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.

Published

Journal Article

Many cancer survivors experience menopausal symptoms, including female survivors taking aromatase inhibitors or with a history of oophorectomy or chemotherapy, and male survivors who received or are receiving androgen-ablative therapies. Sexual dysfunction is also common in cancer survivors. Sexual dysfunction and menopause-related symptoms can increase distress and have a significant negative impact on quality of life. This portion of the NCCN Guidelines for Survivorship provide recommendations for screening, evaluation, and treatment of sexual dysfunction and menopausal symptoms to help healthcare professionals who work with survivors of adult-onset cancer in the posttreatment period.

Full Text

Duke Authors

Cited Authors

  • Denlinger, CS; Sanft, T; Baker, KS; Baxi, S; Broderick, G; Demark-Wahnefried, W; Friedman, DL; Goldman, M; Hudson, M; Khakpour, N; King, A; Koura, D; Kvale, E; Lally, RM; Langbaum, TS; Melisko, M; Montoya, JG; Mooney, K; Moslehi, JJ; O'Connor, T; Overholser, L; Paskett, ED; Peppercorn, J; Rodriguez, MA; Ruddy, KJ; Silverman, P; Smith, S; Syrjala, KL; Tevaarwerk, A; Urba, SG; Wakabayashi, MT; Zee, P; Freedman-Cass, DA; McMillian, NR

Published Date

  • September 2017

Published In

Volume / Issue

  • 15 / 9

Start / End Page

  • 1140 - 1163

PubMed ID

  • 28874599

Pubmed Central ID

  • 28874599

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

International Standard Serial Number (ISSN)

  • 1540-1405

Digital Object Identifier (DOI)

  • 10.6004/jnccn.2017.0146

Language

  • eng